Skip to content

Efficacy of Transdermal Fentanyl for Chronic Neuropathic Pain

CompletedNot applicableNCT00181246
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The efficacy of fentanyl TTS for the treatment of neuropathic pain remains to be established, although opioids in general are clearly effective for neuropathic pain and fentanyl TTS has been shown to be effective for treating other types of pain. We propose to measure functional outcomes, pain relief and side effects of fentanyl TTS for the treatment of neuropathic pain. Measures will be made at baseline and after titrating the drug to an effective level.

Study details

Conditions
Interventions
  • Drug: Transdermal Fentanyl
Sponsor
Johns Hopkins University
Collaborators
PriCara, Unit of Ortho-McNeil, Inc.
Start date
2003-10
Sex
All
Age range
from 18 Years to 75 Years
Results posted
No results posted in this snapshot
Total sites listed
0

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age \>18 years * Neuropathic pain persisting for \> 3 months * Pain over the immediate previous three months * The average of the least and usual pain intensity rating of 3 or greater (0-10 numerical rating scale) during the last week prior to enrollment Exclusion Criteria: * A history of substance abuse * Allergic reaction to an opioid * Significant pain of alternate etiology other than the neuropathic pain state * Severe pulmonary disease * Recent myocardial infarction (within the preceding three months) * Pregnancy * Dementia * Encephalopathy * Those with life expectancy of less than six months and HIV seropositivity.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00181246